Literature DB >> 15609133

Burden of illness imposed by severe sepsis in Germany.

A Schmid1, H Burchardi, J Clouth, H Schneider.   

Abstract

Sepsis is a systemic response to severe infection in critically ill patients and is among the most frequent causes of death in intensive care medicine. Every year between 44,000 and 95,000 persons suffer from this illness in Germany. With the help of a retrospective electronic chart analysis in three adult ICUs of three university hospitals we calculated by a bottom-up approach the direct costs of these patients yielding per patient costs of 23,297 euros on average. Linking the direct costs per patient with the incidence data, the total direct costs for severe sepsis in Germany per year were estimated to range from 1,025 to 2,214 million euros. Direct costs, however, were found to make up only about 28% of the burden of disease of severe sepsis. The indirect costs range between 2,622 and 5,660 million euros. Productivity loss due to premature death does account for the largest part of the indirect costs. In conclusion, severe sepsis imposes annual costs between 3,647 and 7,874 million euros to the German society.

Entities:  

Year:  2002        PMID: 15609133     DOI: 10.1007/s10198-002-0095-8

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  20 in total

Review 1.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

Review 2.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 3.  The Economic and Humanistic Burden of Severe Sepsis.

Authors:  Bogdan Tiru; Ernest K DiNino; Abigail Orenstein; Patrick T Mailloux; Adam Pesaturo; Abhinav Gupta; William T McGee
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

Review 4.  [The cost of sepsis].

Authors:  O Moerer; H Burchardi
Journal:  Anaesthesist       Date:  2006-06       Impact factor: 1.041

5.  A model-based cost-effectiveness analysis of Patient Blood Management.

Authors:  Adina Kleinerüschkamp; Patrick Meybohm; Niels Straub; Kai Zacharowski; Suma Choorapoikayil
Journal:  Blood Transfus       Date:  2018-02-16       Impact factor: 3.443

Review 6.  [Microcirculatory monitoring of sepsis].

Authors:  A Bauer; D Bruegger; F Christ
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

Review 7.  Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.

Authors:  Hilmar Burchardi; Heinz Schneider
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 8.  Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis.

Authors:  James E Frampton; Rachel H Foster
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  A multicentre, prospective study to evaluate costs of septic patients in Brazilian intensive care units.

Authors:  Ana M C Sogayar; Flavia R Machado; Alvaro Rea-Neto; Amselmo Dornas; Cintia M C Grion; Suzana M A Lobo; Bernardo R Tura; Carla L O Silva; Ruy G R Cal; Idal Beer; Vilto Michels; Jorge Safi; Marcia Kayath; Eliezer Silva
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 10.  [Sepsis in adult patients - definitions, epidemiology and economic aspects].

Authors:  O Moerer; M Quintel
Journal:  Internist (Berl)       Date:  2009-07       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.